Additionally, in vivo experiments have confirmed that tumor antigen-specific CD8+ T cells in young mice exhibited stronger cytotoxicity than those in aged mice after anti-PD-L1 therapy (Fig. 2J–K). The gene discussed is CD8A; the disease is neoplasm.